Christelle Foucher

Relationships Between Low-Density Lipoprotein Particle Size, Plasma Lipoproteins, and Progression of Coronary Artery Disease

Juha Vakkilainen, George Steiner, Jean-Claude Ansquer et al. · Circulation · 2003 · 268 citations · Full text

Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: Results from the Diabetes Atherosclerosis Intervention Study (DAIS)

Jean-Claude Ansquer, Christelle Foucher, Stephanie Rattier et al. · American Journal of Kidney Diseases · 2005 · 263 citations

Metabolic Syndrome, Diabetes Management, Fenofibrate Reduces Progression +9

Effect of Fenofibrate on Kidney Function: A 6-Week Randomized Crossover Trial in Healthy People

Jean-Claude Ansquer, R. Neil Dalton, E Caussé et al. · American Journal of Kidney Diseases · 2008 · 102 citations

Healthy People, Urology, Renal Function +8

Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD study

Boris Waldman, Jean-Claude Ansquer, David Sullivan et al. · The Lancet Diabetes & Endocrinology · 2018 · 57 citations

Metabolic Syndrome, Diabetes Management, Field Study +10

Response to micronized fenofibrate treatment is associated with the peroxisome???proliferator-activated receptors alpha G/C intron7 polymorphism in subjects with type 2 diabetes

Christelle Foucher, Stephanie Rattier, David M. Flavell et al. · Pharmacogenetics · 2004 · 47 citations